+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Giapreza"

Cardiovascular Drugs: Global Markets to 2022 - Product Thumbnail Image

Cardiovascular Drugs: Global Markets to 2022

  • Report
  • March 2018
  • 174 Pages
  • Global
From
Hypotension - Pipeline Review, H2 2019 - Product Thumbnail Image

Hypotension - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 54 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Giapreza (angiotensin II) is a cardiovascular drug used to treat hypotension (low blood pressure) in adults with septic or other distributive shock. It is a synthetic form of the naturally occurring hormone angiotensin II, which helps regulate blood pressure. Giapreza is administered intravenously and works by stimulating the production of vasopressin, a hormone that helps regulate blood pressure. It is approved by the U.S. Food and Drug Administration (FDA) for use in adults with septic or other distributive shock. Giapreza is a relatively new drug in the cardiovascular market, and is currently only available in the United States. It is marketed by La Jolla Pharmaceutical Company, and is distributed by specialty pharmacies. Other companies in the cardiovascular drug market include Pfizer, Merck, and Novartis. Show Less Read more